OVID THERAPEUTICS INC (OVID)
US6904691010 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 2.70M | 2.90M | 200.00K | 2.00M | 500.00K | |||
| Cash Equivalents | 24.34M | 42.00M | 187.60M | 70.10M | 41.40M | |||
| Marketable Securities | 78.79M | 84.10M | N/A | 0.00 | 34.80M | |||
| Receivables | N/A | N/A | 0.00 | 100.00K | 1.10M | |||
| Other Current Assets | 3.76M | 2.40M | 2.70M | 2.70M | 1.90M | |||
| Total Current Assets | 109.60M | 131.40M | 190.50M | 74.80M | 79.80M | |||
| Non-Current Assets | ||||||||
| PPE Net | 14.66M | 16.10M | 200.00K | 100.00K | 100.00K | |||
| Investments And Advances | 17.63M | 5.60M | 1.60M | N/A | N/A | |||
| Intangibles | 182.97K | 200.00K | 200.00K | 300.00K | 470.00K | |||
| Other Non-Current Assets | 1.96M | 2.00M | 2.00M | 600.00K | 1.00M | |||
| Total Non-Current Assets | 34.43M | 23.90M | 4.00M | 1.10M | 1.00M | |||
| TOTAL ASSETS | 144.03M | 155.30M | 194.50M | 75.90M | 80.80M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 7.77M | 5.00M | 7.70M | 12.00M | 7.30M | |||
| Accounts Payable | 3.70M | 2.00M | 7.10M | 5.40M | 3.30M | |||
| Other Current Liabilities | N/A | N/A | 0.00 | 4.60M | 0.00 | |||
| Total Current Liabilities | 11.47M | 7.00M | 14.80M | 22.10M | 10.50M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 44.76M | 16.00M | 0.00 | 10.20M | 300.00K | |||
| Total Non-Current Liabilities | 44.76M | 16.00M | 0.00 | 10.20M | 300.00K | |||
| TOTAL LIABILITIES | 56.23M | 23.00M | 14.80M | 32.30M | 10.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -277.87M | -225.50M | -171.40M | -294.20M | -213.20M | |||
| Additional Paid In Capital | 365.59M | 357.80M | 351.00M | 337.80M | 283.10M | |||
| Common Shares | 70.69K | 100.00K | 100.00K | 100.00K | 100.00K | |||
| Other Shareholders' Equity | 700.00 | 0.00 | N/A | 0.00 | 0.00 | |||
| Shares Outstanding | 70.69M | 70.50M | 70.40M | 65.70M | 54.70M | |||
| Tangible Book Value per Share | 1.24 | 1.87 | 2.55 | 0.66 | 1.28 | |||
| Total Shareholders' Equity | 87.80M | 132.30M | 179.70M | 43.60M | 70.00M | |||
| TOTAL LIABILITIES AND EQUITY | 144.03M | 155.30M | 194.50M | 75.90M | 80.80M | |||
| Statistics | ||||||||
| Current Ratio | 9.55 | 18.77 | 12.87 | 3.38 | 7.60 | |||
| Return On Assets (ROA) | -36.34% | -34.90% | 61.59% | -106.72% | -74.88% | |||
| Return On Equity (ROE) | -59.61% | -40.97% | 66.67% | -185.78% | -86.43% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | 54.60% | N/A | N/A | |||
All data in USD